Literature DB >> 17933857

Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy.

Shajil Chalil1, Paul W X Foley, Sarkaw A Muyhaldeen, Kiran C R Patel, Zaheer R Yousef, Russell E A Smith, Michael P Frenneaux, Francisco Leyva.   

Abstract

AIM: To determine whether myocardial scarring, quantified using late gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR), predicts response to cardiac resynchronization therapy (CRT). METHODS AND
RESULTS: A total of 45 patients with ischaemic cardiomyopathy [age 67.1 +/- 10.4 years (mean +/- SD)] underwent assessment of 6 min walking distance (6MWD) and quality of life (QoL) before and after CRT. Scar size (percentage of left ventricular mass), location, and transmurality were assessed prior to CRT using LGE-CMR. Responders (survived for 1 year with no heart failure hospitalizations, and improvement by >or=1 NYHA classes or >or=25% 6MWD) had a higher left ventricular ejection fraction (P = 0.048), smaller scars (<33%) (P = 0.009), and fewer scars with >or=51% transmurality (P = 0.002). Scar size correlated negatively with change in 6MWD (r = -0.54, P < 0.001) and positively with changes in QoL scores (r = 0.35, P = 0.028). Responder rates in patients with <33% scar were higher than in those with >or=33% scar (82 vs. 35%, P < 0.01). Responder rates in patients with scar transmurality <51% were higher than in those with >or=51% (89 vs. 46%, P < 0.01). Among the patients with posterolateral scars, a transmurality value of >or=51% was associated with a particularly poor response rate (23%), compared with scars with <51% transmurality (88%, P < 0.001). In multivariate analyses, both scar size (P = 0.022) and transmurality (P = 0.004) emerged as predictors of response. In patients with posterolateral scars, pacing outside the scar was associated with a better responder rate than pacing over the scar (86 vs. 33%, P = 0.004).
CONCLUSIONS: In patients with ischaemic cardiomyopathy, a scar size >or=33%, a transmurality >or=51%, and pacing over a posterolateral scar are associated with a suboptimal response to CRT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17933857     DOI: 10.1093/europace/eum133

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  47 in total

Review 1.  Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

Authors:  Francisco Leyva; Paul W X Foley
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

2.  High-amplitude left ventricular pacing in cardiac resynchronization therapy: an alternative way to increase response rate in non-responders.

Authors:  Halit Zengin; Filiz Akın; Sabri Demircan; Korhan Soylu; Alirıza Erbay; Serkan Yuksel; Murat Meric; Okan Gulel; Mahmut Sahin; Ozcan Yılmaz
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 3.  Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.

Authors:  Niti R Aggarwal; Matthew W Martinez; Bernard J Gersh; Panithaya Chareonthaitawee
Journal:  Nat Rev Cardiol       Date:  2009-11-03       Impact factor: 32.419

4.  SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response.

Authors:  Michel Lalonde; David Birnie; Terrence D Ruddy; Robert A deKemp; Rob S B Beanlands; Richard Wassenaar; R Glenn Wells
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-09       Impact factor: 2.357

Review 5.  Nonechocardiographic imaging in evaluation for cardiac resynchronization therapy.

Authors:  Wael AlJaroudi; Ji Chen; Wael A Jaber; Steven G Lloyd; Manuel D Cerqueira; Thomas Marwick
Journal:  Circ Cardiovasc Imaging       Date:  2011-05       Impact factor: 7.792

6.  Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy.

Authors:  F Leyva; P W X Foley; B Stegemann; J A Ward; L L Ng; M P Frenneaux; F Regoli; R E A Smith; A Auricchio
Journal:  Heart       Date:  2009-07-09       Impact factor: 5.994

Review 7.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

8.  Impact of contractile reserve on acute response to cardiac resynchronization therapy.

Authors:  Marie Moonen; Mario Senechal; Bernard Cosyns; Pierre Melon; Eric Nellessen; Luc Pierard; Patrizio Lancellotti
Journal:  Cardiovasc Ultrasound       Date:  2008-12-31       Impact factor: 2.062

Review 9.  What is treatment success in cardiac resynchronization therapy?

Authors:  Paul W X Foley; Francisco Leyva; Michael P Frenneaux
Journal:  Europace       Date:  2009-11       Impact factor: 5.214

10.  Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy.

Authors:  Julien Magne; Michelle Dubois; Jean Champagne; Jean G Dumesnil; Philippe Pibarot; François Philippon; Gilles O'Hara; Mario Sénéchal
Journal:  Cardiovasc Ultrasound       Date:  2009-08-20       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.